MarketBeat Instant News Alerts 2 hours agoTarget (NYSE:TGT) Releases Earnings Results, Beats Estimates By $0.25 EPSMarketBeatTarget (NYSE:TGT - Get Free Report) announced its quarterly earnings results on Wednesday. The retailer reported $1.71 EPS for the quarter, topping analysts' consensus estimates of $1.46 by $0.25. The firm had revenue of $25.44 billion during the quarter, compared to analysts' expectations of $24.66 billion. Target had a net margin of 3.54% and a return on equity of 22.25%. NYSE:TGTRead Target (NYSE:TGT) Releases Earnings Results, Beats Estimates By $0.25 EPS2 hours agoTJX Companies (NYSE:TJX) Updates Q2 2027 Earnings GuidanceMarketBeatTJX Companies (NYSE:TJX) updated its second quarter 2027 earnings guidance. The company provided EPS guidance of 1.150-1.170 for the period, compared to the consensus estimate of 1.170. NYSE:TJXRead TJX Companies (NYSE:TJX) Updates Q2 2027 Earnings Guidance2 hours agoTJX Companies (NYSE:TJX) Updates FY 2027 Earnings GuidanceMarketBeatTJX Companies (NYSE:TJX) updated its FY 2027 earnings guidance. The company provided EPS guidance of 5.080-5.150 for the period, compared to the consensus estimate of 5.100. NYSE:TJXRead TJX Companies (NYSE:TJX) Updates FY 2027 Earnings Guidance2 hours agoCAVA Group (NYSE:CAVA) Given New $105.00 Price Target at Stifel NicolausMarketBeatStifel Nicolaus increased their target price on shares of CAVA Group from $90.00 to $105.00 and gave the stock a "buy" rating in a research report on Wednesday.NYSE:CAVARead CAVA Group (NYSE:CAVA) Given New $105.00 Price Target at Stifel Nicolaus2 hours agoCactus (NYSE:WHD) Price Target Raised to $66.00 at Stifel NicolausMarketBeatStifel Nicolaus lifted their target price on Cactus from $59.00 to $66.00 and gave the company a "buy" rating in a report on Wednesday.NYSE:WHDRead Cactus (NYSE:WHD) Price Target Raised to $66.00 at Stifel Nicolaus2 hours agoStifel Nicolaus Forecasts Strong Price Appreciation for Palo Alto Networks (NASDAQ:PANW) StockMarketBeatStifel Nicolaus increased their price target on Palo Alto Networks from $185.00 to $275.00 and gave the stock a "buy" rating in a research report on Wednesday.NASDAQ:PANWRead Stifel Nicolaus Forecasts Strong Price Appreciation for Palo Alto Networks (NASDAQ:PANW) Stock Trending News1Alphabet (NASDAQ:GOOG) Stock Price Down 2.1% After Insider Selling2Mizuho Forecasts Strong Price Appreciation for Micron Technology (NASDAQ:MU) Stock3Morgan Stanley Issues Positive Forecast for NVIDIA (NASDAQ:NVDA) Stock Price4Micron Technology (NASDAQ:MU) Shares Down 6% - Here's What Happened5UiPath, Inc. $PATH Shares Purchased by DNB Asset Management AS6Intel (NASDAQ:INTC) Stock Price Expected to Rise, Citigroup Analyst Says7Intel Corporation $INTC Stock Position Lifted by iA Global Asset Management Inc.8Tesla (NASDAQ:TSLA) Shares Down 4.8% - Here's What Happened All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoRubrik (NYSE:RBRK) Upgraded by Oppenheimer to Outperform RatingMarketBeatNYSE:RBRKRead Rubrik (NYSE:RBRK) Upgraded by Oppenheimer to Outperform Rating2 hours agoStephens Lowers Eagle Materials (NYSE:EXP) Price Target to $225.00MarketBeatNYSE:EXPRead Stephens Lowers Eagle Materials (NYSE:EXP) Price Target to $225.002 hours agoMizuho Cuts Home Depot (NYSE:HD) Price Target to $385.00MarketBeatNYSE:HDRead Mizuho Cuts Home Depot (NYSE:HD) Price Target to $385.002 hours agoQuickLogic (NASDAQ:QUIK) Earns Buy Rating from Analysts at Needham & Company LLCMarketBeatNASDAQ:QUIKRead QuickLogic (NASDAQ:QUIK) Earns Buy Rating from Analysts at Needham & Company LLC2 hours agoImmunityBio's (IBRX) Buy Rating Reaffirmed at HC WainwrightMarketBeatNASDAQ:IBRXRead ImmunityBio's (IBRX) Buy Rating Reaffirmed at HC Wainwright2 hours agoEnphase Energy (NASDAQ:ENPH) Given New $57.00 Price Target at The Goldman Sachs GroupMarketBeatNASDAQ:ENPHRead Enphase Energy (NASDAQ:ENPH) Given New $57.00 Price Target at The Goldman Sachs Group2 hours agoBTIG Research Cuts GAP (NYSE:GAP) Price Target to $28.00MarketBeatNYSE:GAPRead BTIG Research Cuts GAP (NYSE:GAP) Price Target to $28.002 hours agoTD Cowen Reaffirms Buy Rating for CAVA Group (NYSE:CAVA)MarketBeatNYSE:CAVARead TD Cowen Reaffirms Buy Rating for CAVA Group (NYSE:CAVA)2 hours agoAlphabet (NASDAQ:GOOGL) Receives "Buy" Rating from Needham & Company LLCMarketBeatNASDAQ:GOOGLRead Alphabet (NASDAQ:GOOGL) Receives "Buy" Rating from Needham & Company LLC2 hours agoMirum Pharmaceuticals (NASDAQ:MIRM) Upgraded at Wolfe ResearchMarketBeatNASDAQ:MIRMRead Mirum Pharmaceuticals (NASDAQ:MIRM) Upgraded at Wolfe Research2 hours agoAdobe (NASDAQ:ADBE) Stock Rating Lowered by Dbs BankMarketBeatNASDAQ:ADBERead Adobe (NASDAQ:ADBE) Stock Rating Lowered by Dbs Bank2 hours agoStrategy (NASDAQ:MSTR) Lowered to "Strong Sell" Rating by Zacks ResearchMarketBeatNASDAQ:MSTRRead Strategy (NASDAQ:MSTR) Lowered to "Strong Sell" Rating by Zacks Research2 hours agoKiniksa Pharmaceuticals International (NASDAQ:KNSA) Raised to Hold at Zacks ResearchMarketBeatNASDAQ:KNSARead Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Raised to Hold at Zacks Research2 hours agoJabil (NYSE:JBL) Downgraded to "Hold" Rating by Zacks ResearchMarketBeatNYSE:JBLRead Jabil (NYSE:JBL) Downgraded to "Hold" Rating by Zacks Research2 hours agoIonis Pharmaceuticals (NASDAQ:IONS) Stock Rating Upgraded by CitigroupMarketBeatNASDAQ:IONSRead Ionis Pharmaceuticals (NASDAQ:IONS) Stock Rating Upgraded by Citigroup2 hours agoCytokinetics (NASDAQ:CYTK) Upgraded by Citigroup to "Strong-Buy" RatingMarketBeatNASDAQ:CYTKRead Cytokinetics (NASDAQ:CYTK) Upgraded by Citigroup to "Strong-Buy" Rating2 hours agoAlnylam Pharmaceuticals (NASDAQ:ALNY) Rating Increased to Strong-Buy at CitigroupMarketBeatNASDAQ:ALNYRead Alnylam Pharmaceuticals (NASDAQ:ALNY) Rating Increased to Strong-Buy at Citigroup2 hours agoAnalog Devices (NASDAQ:ADI) Updates Q3 2026 Earnings GuidanceMarketBeatNASDAQ:ADIRead Analog Devices (NASDAQ:ADI) Updates Q3 2026 Earnings Guidance3 hours agoSEA (NYSE:SE) Insider Sells 800 SharesMarketBeatNYSE:SERead SEA (NYSE:SE) Insider Sells 800 Shares3 hours agoSEA (NYSE:SE) Insider Sells $70,448.00 in StockMarketBeatNYSE:SERead SEA (NYSE:SE) Insider Sells $70,448.00 in Stock3 hours agoSEA (NYSE:SE) COO Sells $881,100.00 in StockMarketBeatNYSE:SERead SEA (NYSE:SE) COO Sells $881,100.00 in Stock3 hours agoFY2027 Earnings Forecast for ASML Issued By Erste Group BankMarketBeatNASDAQ:ASMLRead FY2027 Earnings Forecast for ASML Issued By Erste Group Bank3 hours agoFY2027 Earnings Forecast for NVO Issued By Erste Group BankMarketBeatNYSE:NVORead FY2027 Earnings Forecast for NVO Issued By Erste Group Bank3 hours agoFY2027 EPS Estimates for Shell Cut by Erste Group BankMarketBeatNYSE:SHELRead FY2027 EPS Estimates for Shell Cut by Erste Group Bank Featured Articles and OffersRobinhood, SoFi, and Webull Are Telling Very Different StoriesBy Peter Frank | May 17, 2026I was right about SpaceXFrom Brownstone Research (Ad)Why Applied Optoelectronics Stock May Be Near a Turning PointBy Thomas Hughes | May 18, 2026How the 3 Leading Quantum Firms Stack Up After Q1 EarningsBy Nathan Reiff | May 14, 20263 Stocks to Own If Gas Prices Keep RisingBy Dan Schmidt | May 16, 2026This Biotech Just Flipped From Story to ExecutionFrom Equiscreen (Ad)Alphabet (NASDAQ:GOOG) Stock Price Down 2.1% After Insider SellingBy MarketBeat | May 19, 2026Datavault Gains Traction: 5 Reasons to Sell NowBy Thomas Hughes | May 18, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 238 1234567 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
